These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1377461)

  • 1. Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia.
    Geissler K; Forstinger C; Kalhs P; Knöbl P; Kier P; Kyrle P; Lechner K
    Ann Intern Med; 1992 Aug; 117(3):223-5. PubMed ID: 1377461
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
    Matsuo Y; Iwanaga M; Mori H; Yoshida S; Kawaguchi Y; Yakata Y; Murata K; Nagai K; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
    Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The successful treatment of two cases of severe aplastic anaemia with granulocyte-colony stimulating factor and cyclosporine A.
    Bertrand Y; Amri F; Capdeville R; Ffrench M; Philippe N
    Br J Haematol; 1991 Dec; 79(4):648-9. PubMed ID: 1722994
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
    Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
    Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3.
    Schleuning M; Thomssen C; Kolb HJ; Sauer HJ; Wilmanns W
    Am J Hematol; 1994 Jul; 46(3):250-1. PubMed ID: 7514849
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia.
    Imamura M; Kobayashi M; Kobayashi S; Yoshida K; Mikuni C; Ishikawa Y; Matsumoto S; Sakamaki S; Niitsu Y; Hinoda Y
    Am J Hematol; 1995 Jan; 48(1):29-33. PubMed ID: 7530405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 9. Overuse of granulocyte colony-stimulating factor in acute myeloid leukemia, aplastic anemia and myelodysplastic syndrome.
    Shinohara K
    Intern Med; 2000 Jan; 39(1):82. PubMed ID: 10674858
    [No Abstract]   [Full Text] [Related]  

  • 10. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia.
    Gluckman E; Rokicka-Milewska R; Hann I; Nikiforakis E; Tavakoli F; Cohen-Scali S; Bacigalupo A;
    Br J Haematol; 2002 Dec; 119(4):1075-82. PubMed ID: 12472591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies].
    Miyairi Y; Murai K; Utsugisawa T; Narigasawa Y; Ito S; Shimosegawa K; Sugawara T; Numaoka H; Ono Y; Ito T; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1996 Jan; 37(1):22-8. PubMed ID: 8683863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic value of interleukin-3 given alone or in combination with other cytokines.
    Ganser A; Hoelzer D
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):245-6. PubMed ID: 8337137
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
    Yoshida Y; Asano S; Hirashima K; Takaku F
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():349-52. PubMed ID: 1284304
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.
    Jakucs J; Pocsay G
    J Endocrinol Invest; 2006 Jan; 29(1):74-7. PubMed ID: 16553037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.
    Herrmann F; Lindemann A; Lange W; Köchling G; Raghavachar A; Schrezenmeier H; Frickhofen N; Mertelsmann RH
    Ann Hematol; 1991 Oct; 63(4):229-31. PubMed ID: 1932305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K
    Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.